An expert explains the treatment of retinal vein occlusion

Written in association with: Mrs Samantha Mann
Published: | Updated: 13/09/2022
Edited by: Lauren Dempsey

The retina is a thin layer of tissue at the very back of the eye, made up of different types of cells which allow us to see. It is responsible for interpreting light which is transmitted to the brain to form an image. If a blockage occurs in a vein of the retina, it can lead to a deterioration of one’s vision. Highly-esteemed, London-based consultant ophthalmologist Mrs Samantha Mann, who specialises in the treatment of conditions affecting the retina, shares her expertise on retinal vein occlusion.

What is retinal vein occlusion? Is it serious? 

A vein occlusion is when there is a blockage of one of the veins at the back of the eye on the retina. The retina is the very thin film on the inner surface of the back of the eye that allows us to see. This blockage can occur in one of the branches of the main veins, called a branch retinal vein occlusion (BRVO), which can cause loss of vision in either the top or bottom part of your sight. The blockage can also occur in the main central vein, which is called a central retinal vein occlusion (CRVO) which tends to be more serious resulting in loss of vision in the central area. Although both of these conditions can result in reduced vision, the majority of these can be treated if diagnosed early, although treatment is often for a prolonged period of time. 

 

What is the most common cause of retinal vein occlusion? 

The blockage in the vein is often due to a blood clot that obstructs the blood flow in the vein. The most common conditions that are associated with venous occlusions are:

 

Can you go blind from retinal vein occlusion?

It is rare to totally lose your vision from vein occlusions but swelling often occurs from damaged blood vessels at the central part of the retina, causing blurring of central vision. This swelling can be treated with anti-vascular endothelial growth factor (anti-VEGF) or steroid medications. If. If the blood supply is very damaged at the back of the eye following a vein occlusion, it is possible for the vision to be reduced permanently. This is due to abnormal blood vessels growing towards the front of the eye, blocking drainage of fluid from the eye, and causing a rise in pressure. If this occurs, laser treatment may be required to reduce the growth of the blood vessels. 

 

Can retinal vein occlusion go away on its own? 

Some forms of branch retinal vein occlusion, if mild, can get better on their own over a few months, as the eye recovers. Most vein occlusions, particularly central retinal vein occlusions, require some treatment to be given, at least for a few months. 

 

Is there any cure for retinal vein occlusion? 

Unfortunately, there is no way to unblock the venous occlusion, but the swelling of the retina and any growth of abnormal blood vessels can be treated to improve and stabilise the vision over the long term. 

 

What is the best treatment for retinal vein occlusion? 

The best treatment for venous occlusion depends on the extent of the occlusion and whether the damaged vessels have resulted in swelling of the central part of the retina. Anti-VEGF injection treatment or steroid injection treatment into the eye have been shown to be effective at reducing the leakage at the back of the eye and improving vision. These injections, however, have to be repeated regularly as the effect of the drug wears off  usually after four-to-eight weeks. These injections can safely and quickly be given into the eye as an outpatient without too much discomfort. 

If abnormal blood vessels grow towards the front of the eye (which usually occurs more frequently in CRVO), laser treatment may need to be applied to the retina. Again, this can be carried out easily as an outpatient. Although the laser treatment does not improve the vision, it can help to stabilise it.

 

Retinal vein occlusion can cause serious damage to your vision if it is left untreated. If you are experiencing any of the symptoms mentioned above and would like to book a consultation with leading London-based consultant ophthalmologist Mrs Samantha Mann, you can do so by visiting her Top Doctors profile today.

By Mrs Samantha Mann
Ophthalmology

Mrs Samantha Mann is a leading consultant ophthalmologist specialising in medical retina who treats patients from in and around London. With over 25 years of experience, she is highly specialised in the treatment of conditions affecting the retina such as diabetic retinopathy, age-related macular degeneration, retinal vein occlusion, and central serous retinopathy. Additionally, Mrs Mann is an expert in intravitreal injections of both anti-VEGF agents and steroid implants and retinal laser treatments.   
  
In 1996, Mrs Mann qualified as a doctor from St Bartholomew’s hospital in London with distinction and first-class honours in her intercalated BSc. She then gained general medical experience as she trained in various London hospitals before pursuing a career in ophthalmology. Part of her ophthalmic rotation was spent at St Thomas’ hospital after which she spent five years as a specialist registrar and fellow at Moorfield’s Eye Hospital, during which she completed and was awarded an MD for her research into age-related macular degeneration. She was also awarded the Harcourt Medal by the Royal College of Ophthalmologists in 2001 for her performance in her final examinations. 
  
Mrs Mann is currently a consultant ophthalmologist at her NHS base, Guy’s and St Thomas’ Hospital, where she has practised since 2009. Here, she is one of three medical retinal consultants. Privately, she sees patients at the renowned London Medical Clinic. Furthermore, she is the clinical lead for South East London’s Diabetic Eye Screening Programme, which is responsible for over 120,000 patients with diabetes. She also led the production of a video entitled ‘Danny’s Story’ emphasising the importance of eye screening for patients with diabetes. 
  
In addition to her clinical work, Mrs Mann maintains a keen research interest, particularly in age-related macular disease and diabetic eye screening. She has authored numerous peer-reviewed papers. Currently, she is the principal investigator of Thomas’ Hospital’s PINNACLE study, having previously held the role in two vein occlusion treatment trials. Over the last 10 years she has had an active role in teaching and running courses for trainees and other health professionals on diabetic retinopathy, laser for diabetes, and on the progression of retinopathy in pregnancy.  She is also a Fellow of the Royal College of Ophthalmologists.   

View Profile

Overall assessment of their patients


  • Related procedures
  • Microdermoabrasion
    Microneedling
    Dark circles
    Mesotherapy
    Facelift
    Neck lift
    Botulinum toxin (Botox™)
    Dermal fillers
    Peeling
    Facial paralysis
    This website uses our own and third-party Cookies to compile information with the aim of improving our services, to show you advertising related to your preferences as well analysing your browsing habits. You can change your settings HERE.